A Study of LY3200882 in Participants With Solid Tumors

Running, not enrolling · Phase 1

Conditions studied: Solid Tumor

In brief

The main purpose of this study is to evaluate the safety of the study drug known as LY3200882 in participants with solid tumors.

Key facts

Study ID
NCT02937272
Run by
Eli Lilly and Company
People needed
223
Starts
2016-11-21
Expected to finish
2027-08-01
Last updated by the study team
2026-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.